SPRO Spero Therapeutics, Inc. gains 17% Mar 23, 2018

SmartPros Ltd. provides learning and educational solutions for accounting/finance, legal, engineering, securities, and insurance markets. It offers accounting and finance libraries; executive enterprise institute, a series of live seminars in the corporate and public accountant marketplace; SmartPros Advantage, a skills-based learning library; and Financial Management Network, a library of programs dealing with current topics. The company also provides CPA Report (CPAR), a library of programs covering topics in public accounting; and CPAR Government and Not-for-Profit, a library of designed for accounting professionals. Its engineering library includes FE Exam Review, a preparatory course for the basic entry-level licensing exam; PE Civil Exam review, a course for civil engineers; and a series of self-study PE Civil Exam preparation courses that cover the civil, mechanical, electrical, and chemical disciplines. In addition, the company offers engineering and management courses for professional development hours; project management for engineers; construction project management; and supply chain and certified in production and inventory management certification courses. Further, it provides online educational courses covering Occupational Safety and Health Act regulatory compliance, hazardous material handling, and environmental and safety topics. Additionally, the company develops corporate governance, compliance, and ethics programs for employees and managers; and provides continuing legal education courses. The company also offers online courses for the banking, insurance, and securities industries; and information technology courses programs. Its courses are offered in text and video-interactive formats, live education, and Webinars. The company was formerly known as KeepSmart.com, Inc. and changed its name to SmartPros Ltd. in June 2001. SmartPros Ltd. was founded in 1981 and is headquartered in Hawthorne, New York. http://www.priceseries.com/trade/SPRO-Spero-Therapeutics-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2018030820180323.html